Australian researchers have demonstrated for the first time that heart attacks trigger the division of cardiomyocytes—the heart's primary muscle cells—in adults. This discovery upends the long-standing belief that the adult heart lacks regenerative capabilities and offers a genuine, albeit modest, starting point for therapies designed to boost natural heart muscle repair.
Myocardial infarction remains the world's leading cause of death. A single event can destroy up to one-third of the roughly three billion cardiomyocytes in a human heart. For decades, it was thought that adult cardiomyocytes were nearly incapable of dividing, with scar tissue replacing dead cells—a process that impairs pumping function and leads to heart failure.
A study published in January 2026 in the journal Circulation Research (DOI: 10.1161/CIRCRESAHA.125.327486) has finally provided evidence to the contrary in humans. Led by Dr. Robert D. Hume (University of Sydney, Charles Perkins Centre, Baird Institute) and Professor Sean Lal (University of Sydney and Royal Prince Alfred Hospital), the team utilized unique live heart tissue samples obtained during coronary artery bypass surgeries.
Samples were collected from both ischemic zones and relatively healthy areas. The researchers employed immunofluorescent staining for mitosis and cytokinesis markers, bulk and single-nucleus RNA sequencing, proteomics, and metabolomics, while also analyzing the largest available human heart attack snRNA-seq dataset. The findings are definitive: adult human ventricular cardiomyocytes do increase mitotic activity and complete cell division (cytokinesis) in response to ischemia.
While this response to a heart attack has been well-documented in rodent models, direct evidence in humans was previously lacking. It has now been confirmed through the study of living human tissue rather than relying solely on post-mortem data.
This is significant for patients for several reasons. Heart failure following an attack is a widespread issue; in Australia alone, approximately 144,000 people live with the condition, yet only about 115 heart transplants are performed annually. If researchers can find a pharmacological or other method to amplify this existing mechanism, it could slow or partially reverse heart failure without the need for extreme measures like transplantation. The team has already identified several proteins involved in the process—previously known from mouse studies—which can now be targeted for research in human samples.
However, the implications must not be overstated. While mitosis does increase, the scale appears limited and is currently insufficient to compensate for the massive cell loss seen in major heart attacks. The study does not offer an immediate cure; instead, it proves a latent regenerative response exists and provides a foundation for future work. It also remains unknown how safely or effectively this process can be stimulated in specific patients, or what the long-term effects of such activation might be.
What comes next? The group is already refining techniques to obtain and study live heart samples specifically to identify ways to boost regeneration. Future phases will involve deeper molecular analysis of the regulatory proteins found, testing candidate molecules in human tissue models, and eventually moving toward preclinical and clinical trials. The central question now facing scientists is how effectively and precisely we can "nudge" the heart toward self-repair without introducing new risks.
This research is not a promise of a miracle, but a precise and vital piece of scientific evidence: the adult human heart is not entirely devoid of the ability to regenerate muscle tissue. It possesses its own recovery toolkit, however limited. The challenge for medicine now is learning how to use it effectively.
